These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients. Sabuncu T; Arikan E; Tasan E; Hatemi H Intern Med; 2001 Sep; 40(9):857-61. PubMed ID: 11579944 [TBL] [Abstract][Full Text] [Related]
8. Clinical course and outcome of thirty-five pregnancies in infertile hyperprolactinemic women. Skrabanek P; McDonald D; Meagher D; de Valera E; Carroll C; Lanigan O; Powell D Fertil Steril; 1980 Apr; 33(4):391-5. PubMed ID: 7364069 [TBL] [Abstract][Full Text] [Related]
9. Pregnancy in hyperprolactinemic infertile women treated with vaginal bromocriptine: report of two cases and review of the literature. Ricci G; Giolo E; Nucera G; Pozzobon C; De Seta F; Guaschino S Gynecol Obstet Invest; 2001; 51(4):266-70. PubMed ID: 11408739 [TBL] [Abstract][Full Text] [Related]
10. Hyperprolactinemia in oligospermic Nigerian males: effect of bromocriptine treatment. Modebe O Int J Fertil Menopausal Stud; 1994; 39(2):95-9. PubMed ID: 8012447 [TBL] [Abstract][Full Text] [Related]
11. Clinical and hormonal response to short-term intermittent versus continuous oral bromocriptine in hyperprolactinemic women. Parra A; Crespo G; Coria I; Espinosa de los Monteros A Int J Fertil Menopausal Stud; 1995; 40(2):96-101. PubMed ID: 7599666 [TBL] [Abstract][Full Text] [Related]
12. Hyperprolactinemia presenting with encephalomalacia-associated seizure disorder and infertility: a novel application for bromocriptine therapy in reproductive endocrinology. Saie DJ; Sills ES Neuro Endocrinol Lett; 2005 Oct; 26(5):533-5. PubMed ID: 16264405 [TBL] [Abstract][Full Text] [Related]
13. Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women. Yavuz D; Deyneli O; Akpinar I; Yildiz E; Gözü H; Sezgin O; Haklar G; Akalin S Eur J Endocrinol; 2003 Sep; 149(3):187-93. PubMed ID: 12943520 [TBL] [Abstract][Full Text] [Related]
14. High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage. Nardo LG; Rai R; Backos M; El-Gaddal S; Regan L Fertil Steril; 2002 Feb; 77(2):348-52. PubMed ID: 11821095 [TBL] [Abstract][Full Text] [Related]
15. Galactorrhea in a 14-year-old girl. Panamonta O; Pakawut N J Med Assoc Thai; 2006 Aug; 89(8):1304-7. PubMed ID: 17048445 [TBL] [Abstract][Full Text] [Related]
16. Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial. Clifford K; Rai R; Watson H; Franks S; Regan L BMJ; 1996 Jun; 312(7045):1508-11. PubMed ID: 8646142 [TBL] [Abstract][Full Text] [Related]
17. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case]. Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885 [TBL] [Abstract][Full Text] [Related]
18. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level. Parsanezhad ME; Alborzi S; Jahromi BN Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169 [TBL] [Abstract][Full Text] [Related]
19. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials. Saccone G; Schoen C; Franasiak JM; Scott RT; Berghella V Fertil Steril; 2017 Feb; 107(2):430-438.e3. PubMed ID: 27887710 [TBL] [Abstract][Full Text] [Related]
20. [Study on hyperprolactinemic anovulatory syndrome and treatment with bromocriptine (author's transl)]. Fukunaga T Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):229-38. PubMed ID: 7015779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]